Amgen

Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Xtalks
Fri, 04/6/18 - 11:26 am
Amgen
Repatha
outcome-based pricing
drug pricing
patients
Amgen's money-back offer on Repatha isn't all that meaningful, researchers find
Biopharma Dive
Wed, 04/4/18 - 10:12 pm
Amgen
Repatha
Amgen darkens the mood in new Repatha TV ads, warning of heart and stroke risks
Fierce Pharma
Wed, 04/4/18 - 09:03 am
Amgen
Repatha
DTC ads
heart attack
stroke
Will Blincyto's Expanded FDA Approval Open the Door for Wider Use of MRD as a Biomarker or Endpoint?
RAPS.org
Tue, 04/3/18 - 11:04 pm
Amgen
Blincyto
ALL
B-cell precursor ALL
Novartis Likely Delayed In Launching Copycat Of Amgen Blockbuster
Investors Business Daily
Fri, 03/30/18 - 09:26 am
Novartis
Amgen
Enbrel
biosimilars
Investors in AbbVie, Lilly, Amgen and more set to vote on executive pay, drug pricing
Fierce Pharma
Tue, 03/27/18 - 10:00 pm
AbbVie
Eli Lilly
Amgen
executive pay
drug pricing
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Xtalks
Mon, 03/26/18 - 09:36 am
Amgen
Allergan
Herceptin
biosimilars
ABP 980
CHMP
EMA
Roche
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger
Investors Business Daily
Mon, 03/19/18 - 12:07 pm
Amgen
Celgene
M&A
Alexion
AstraZeneca
Drug companies are beginning to wake up to this new risk factor
Marketwatch
Mon, 03/19/18 - 12:05 pm
pharma industry
co-pay coupons
Pfizer
Sanofi
Amgen
Novartis
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Tue, 03/13/18 - 09:30 pm
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
Top 5 boards for week ending March 10, 2018
CP Wire
Sun, 03/11/18 - 03:05 pm
Daiichi Sankyo
Shire
Amgen
Sanofi
AstraZeneca
FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
FDA
generics
Amgen
Sensipar
Cipla
Aurobindo
Top 5 viewed boards for week ending March 3, 2018
CP Wire
Sun, 03/4/18 - 01:50 pm
cafepharma
Daiichi Sankyo
Shire
Allergan
Amgen
Sanofi
sales meeting
layoffs
Esmya
Pfizer
Celgene
M&A
Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble
Fierce Pharma
Thu, 02/22/18 - 11:28 pm
migraines
NASH
Amgen
Eli Lilly
Teva Pharmaceutical
Allergan
Gilead Sciences
Novo Nordisk
Intercept Pharma
PBMs
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
Sun, 02/18/18 - 10:16 am
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
3 Tough Questions for Amgen
Motley Fool
Thu, 02/15/18 - 09:37 am
Amgen
payers
cash
margins
Amgen still far from performing an important acquisition
GoinPharma
Sun, 02/11/18 - 06:23 pm
Amgen
M&A
Amgen Q4 Earnings Results: 2 Things to Hate and 2 Things to Like
Motley Fool
Sun, 02/4/18 - 11:45 am
Amgen
earnings
Amgen reports profit below analyst views, but beats expectations on earnings outlook
CNBC
Fri, 02/2/18 - 09:33 am
Amgen
earnings

Pages